Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

Study finds more than 40 percent of prostate biopsies could be avoided with new blood test

Study finds more than 40 percent of prostate biopsies could be avoided with new blood test

FDA issues health alert for clinical trials treating low PD-L1 bladder cancer with pembrolizumab or atezolizumab

FDA issues health alert for clinical trials treating low PD-L1 bladder cancer with pembrolizumab or atezolizumab

Finasteride does not increase risk of prostate cancer death, SWOG results show

Finasteride does not increase risk of prostate cancer death, SWOG results show

Salvage cryoablation shows clinical benefit in delaying hormone therapy for men with locally recurrent prostate cancer

Salvage cryoablation shows clinical benefit in delaying hormone therapy for men with locally recurrent prostate...

European Commission approves cabozantinib for the first-line treatment of adults with intermediate/poor-risk advanced renal cell carcinoma

European Commission approves cabozantinib for the first-line treatment of adults with intermediate/poor-risk...

Bone scan software accurately calculates prognosis of advanced prostate cancer

Bone scan software accurately calculates prognosis of advanced prostate cancer

VA health care successfully reduces 'rush to treatment' rates for low-risk prostate cancer

VA health care successfully reduces 'rush to treatment' rates for low-risk prostate cancer

Genetic fixer-uppers may help predict bladder cancer prognosis

Genetic fixer-uppers may help predict bladder cancer prognosis

Study shows targeted biopsy for prostate cancer more effective than traditional method

Study shows targeted biopsy for prostate cancer more effective than traditional method

Computational strategy designed for more personalised cancer treatment

Computational strategy designed for more personalised cancer treatment

More from ecancer